SimplicityBio is Swiss based company, founded in 2015 and active in the discovery of novel medical biomarkers by means of its patented bioinformatics machine-learning technology.
Our vision is to be the leading biomarker discovery company by 2020 powering the new generation of diagnostic tests and drugs changing forever the lives of millions of people around the world.
SimplicityBio has developed a software platform for the analysis of big and complex biological data. We co-develop diagnostic tests enabling diagnostic companies to discover new accurate and robust biomarker, and help pharmaceutical companies to discover the populations that respond to a given drug.
News
Milestones/News
Documents
Videos and Presentations
LAGOSTA
